Relationship between genetic alteration of the rpsL gene and streptomycin susceptibility of Mycobacterium tuberculosis in Japan

Journal of Antimicrobial Chemotherapy

Volumn 43, Issue 2, 1999, Pages 281-284

  Fukuda, Miho ^a   Koga, Hironobu ^a   Ohno, Hideaki ^a   Yang, Bing ^a   Hirakata, Yoichi ^a   Maesaki, Shigefumi ^a   Tomono, Kazunori ^a   Tashiro, Takayoshi ^a   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

STREPTOMYCIN;

AMINO ACID COMPOSITION; ANTIBIOTIC RESISTANCE; ARTICLE; CODON; DNA SEQUENCE; DRUG SCREENING; GENE MUTATION; JAPAN; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; PREDICTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; DRUG RESISTANCE, MICROBIAL; JAPAN; MICROBIAL SENSITIVITY TESTS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RIBOSOMAL PROTEINS; SEQUENCE ANALYSIS, DNA; STREPTOMYCIN;

EID: 0033001980     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/43.2.281     Document Type: Article

References (10)

1. Jacobs, W. R., Barletta, R. G., Udani, R., Chan, J., Kalkut, G., Sosne, G. et al. (1993). Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages. Science 260, 819-22.
2. Van der Vliet, G. M., Schepers, P., Schukkink, R. A. F., Van Gemen, B. & Klatser, P. R. (1994). Assessment of mycobacterial viability by RNA amplification. Antimicrobial Agents and Chemotherapy 38, 1959-65.
3. Miyamoto, J., Koga, H., Kohno, S., Tashiro, T. & Hara, K. (1996). New drug susceptibility test for Mycobacterium tuberculosis using the hybridization protection assay. Journal of Clinical Microbiology 34, 1323-6.
4. Ohno, H., Koga, H., Kuroita, T., Tomono, K., Ogawa, K., Yanagihara, K. et al. (1997). Rapid prediction of rifampin susceptibility of Mycobacterium tuberculosis. American Journal of Respiratory and Critical Care Medicine 155, 2057-63.
5. Ohno, H., Koga, H., Kohno, S., Tashiro, T. & Hara, K. (1996). Relationship between rifampin MICs for and rpoB mutations of Mycobacterium tuberculosis strains isolated in Japan. Antimicrobial Agents and Chemotherapy 40, 1053-6.
6. Meier, A., Kirschner, P., Bange, F.-C., Vogel, U. & Bottger, E. C. (1994). Genetic alterations in streptomycin-resistant Mycobacterium tuberculosis: mapping of mutations conferring resistance. Antimicrobial Agents and Chemotherapy 38, 228-33.
7. Honore, N., Marchal, G. & Cole, S. T. (1995). Novel mutation in 16S rRNA associated with streptomycin dependence in Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy 39, 769-70.
8. Cooksey, R. C., Morlock, G. P., McQueen, A., Glickman, S. E. & Crawford, J. T. (1996). Characterization of streptomycin resistance mechanisms among Mycobacterium tuberculosis isolates from patients in New York City. Antimicrobial Agents and Chemotherapy 40, 1186-8.
9. Sreevatsan, S., Pan, X., Stockbauer, K. E., Williams, D. L., Kreiswirth, B. N. & Musser, J. M. (1996). Characterization of rpsL and rrs mutations in streptomycin-resistant Mycobacterium tuberculosis isolates from diverse geographic localities. Antimicrobial Agents and Chemotherapy 40, 1024-6.
10. Meier, A., Sander, P., Schaper, K.-J., Scholz, M. & Bottger, E. C. (1996). Correlation of molecular resistance mechanisms and phenotypic resistance levels in streptomycin-resistant Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy 40, 2452-4.